
### [NCIT:C3088](http://purl.obolibrary.org/obo/NCIT_C3088)
**Label:** Angiosarcoma

**Subclasses:** [NCIT:C5528](http://purl.obolibrary.org/obo/NCIT_C5528) (Prostate Angiosarcoma), [NCIT:C6479](http://purl.obolibrary.org/obo/NCIT_C6479) (Bone Angiosarcoma), [NCIT:C5840](http://purl.obolibrary.org/obo/NCIT_C5840) (Gallbladder Angiosarcoma), [NCIT:C9426](http://purl.obolibrary.org/obo/NCIT_C9426) (Conventional Angiosarcoma), [NCIT:C6613](http://purl.obolibrary.org/obo/NCIT_C6613) (Mediastinal Angiosarcoma), [NCIT:C96511](http://purl.obolibrary.org/obo/NCIT_C96511) (Colorectal Angiosarcoma), [NCIT:C5385](http://purl.obolibrary.org/obo/NCIT_C5385) (Uterine Angiosarcoma), [NCIT:C5320](http://purl.obolibrary.org/obo/NCIT_C5320) (Peripheral Intraneural Angiosarcoma), [NCIT:C27513](http://purl.obolibrary.org/obo/NCIT_C27513) (Radiation-Related Angiosarcoma), [NCIT:C5184](http://purl.obolibrary.org/obo/NCIT_C5184) (Breast Angiosarcoma), [NCIT:C27512](http://purl.obolibrary.org/obo/NCIT_C27512) (Angiosarcoma Associated with Lymphedema), [NCIT:C5384](http://purl.obolibrary.org/obo/NCIT_C5384) (Recurrent Angiosarcoma), [NCIT:C9174](http://purl.obolibrary.org/obo/NCIT_C9174) (Childhood Angiosarcoma), [NCIT:C9031](http://purl.obolibrary.org/obo/NCIT_C9031) (Poorly Differentiated Angiosarcoma), [NCIT:C121671](http://purl.obolibrary.org/obo/NCIT_C121671) (Angiosarcoma of Soft Tissue), [NCIT:C27719](http://purl.obolibrary.org/obo/NCIT_C27719) (Cutaneous Radiation-Related Angiosarcoma), [NCIT:C128049](http://purl.obolibrary.org/obo/NCIT_C128049) (Cervical Angiosarcoma), [NCIT:C6746](http://purl.obolibrary.org/obo/NCIT_C6746) (Pulmonary Artery Angiosarcoma), [NCIT:C5378](http://purl.obolibrary.org/obo/NCIT_C5378) (Superior Vena Cava Angiosarcoma), [NCIT:C4564](http://purl.obolibrary.org/obo/NCIT_C4564) (Splenic Angiosarcoma), [NCIT:C4489](http://purl.obolibrary.org/obo/NCIT_C4489) (Skin Angiosarcoma), [NCIT:C48320](http://purl.obolibrary.org/obo/NCIT_C48320) (Adrenal Gland Angiosarcoma), [NCIT:C5232](http://purl.obolibrary.org/obo/NCIT_C5232) (Ovarian Angiosarcoma), [NCIT:C9411](http://purl.obolibrary.org/obo/NCIT_C9411) (Angiosarcoma NCI Grade 2), [NCIT:C5376](http://purl.obolibrary.org/obo/NCIT_C5376) (Aortic Angiosarcoma), [NCIT:C133092](http://purl.obolibrary.org/obo/NCIT_C133092) (Recurrent Breast Angiosarcoma), [NCIT:C9412](http://purl.obolibrary.org/obo/NCIT_C9412) (Angiosarcoma NCI Grade 3), [NCIT:C96060](http://purl.obolibrary.org/obo/NCIT_C96060) (Small Intestinal Angiosarcoma), [NCIT:C9275](http://purl.obolibrary.org/obo/NCIT_C9275) (Primary Angiosarcoma), [NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema), [NCIT:C6043](http://purl.obolibrary.org/obo/NCIT_C6043) (Thyroid Gland Angiosarcoma), [NCIT:C5450](http://purl.obolibrary.org/obo/NCIT_C5450) (Central Nervous System Angiosarcoma), [NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma), [NCIT:C9040](http://purl.obolibrary.org/obo/NCIT_C9040) (Adult Angiosarcoma), [NCIT:C8708](http://purl.obolibrary.org/obo/NCIT_C8708) (Metastatic Angiosarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.49%
- [CL:0000115](http://purl.obolibrary.org/obo/CL_0000115) (endothelial cell) 52.63%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) and (not ([CL:0000214](http://purl.obolibrary.org/obo/CL_0000214) (synovial cell))) 37.99%
- [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) 31.50%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) 31.50%
- [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) and [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 31.50%
- [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) and [CL:0002078](http://purl.obolibrary.org/obo/CL_0002078) (meso-epithelial cell) 31.50%
- [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) and [CL:0000548](http://purl.obolibrary.org/obo/CL_0000548) (animal cell) 31.50%
- [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) and [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 31.50%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) and [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 31.50%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) and [CL:0002078](http://purl.obolibrary.org/obo/CL_0002078) (meso-epithelial cell) 31.50%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) and [CL:0000548](http://purl.obolibrary.org/obo/CL_0000548) (animal cell) 31.50%
- [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) and [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 31.50%
- [CL:0000066](http://purl.obolibrary.org/obo/CL_0000066) (epithelial cell) and [CL:0000215](http://purl.obolibrary.org/obo/CL_0000215) (barrier cell) 31.50%
- [CL:0000066](http://purl.obolibrary.org/obo/CL_0000066) (epithelial cell) and [CL:0000213](http://purl.obolibrary.org/obo/CL_0000213) (lining cell) 31.50%


